Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Age-Restriction Labeling, Behind-The-Counter Sales Likely In HRA's US OTC Contraceptive NDA

Aug 25 2022

• By Malcolm Spicer

• Source: Shutterstock

Related Content

Plan B Ruling: Little Commercial Impact, Big Policy Implications

Mar 30 2009

Court Ruling Compels Emergency Contraceptives Over The Counter

Apr 08 2013

Political Winds, Like Previous Storms Over US FDA Decisions, Stir Around OTC Contraceptive Proposal

Aug 25 2022

OTC Daily Oral Contraceptive Proposal In US Packs Promise Of Access, But Peril Of Single Option

Aug 23 2022

US OTC Birth Control NDA Could Debut ‘Additional Conditions for Nonprescription Use’ Labeling

Aug 23 2022

Likely Limits On Reproductive Rights Drive Democrats’ Urgency For OTC Oral Contraceptive

Jun 10 2022

US FDA Has 10 Months To Provide Answer On Perrigo/HRA OTC Oral Contraceptive Application

Jul 12 2022

Related Companies

Perrigo Company PLC

Additional Topics

International United States US States FDA Politics Prescription To OTC Switch Advertising, Marketing & Sales Business Strategies Clinical Trials Commercial Companies Compliance Consumer Drug Approval Standards Enforcement Ingredients Manufacturing Legislation OTC Drugs Policy Regulation Retail Gynecology & Urology

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window